About Persist AI
Overview
Why we're building Persist
OUR HISTORY
AI-driven drug discovery is leading to a new era of novel drug molecules and targets. Our team believes that these drugs will hold the key to a healthier and happier future for all of our families. This is why we're building our next generation drug formulation platform.
How we're building Persist
COMPANY VALUES
We have a close-knit team of scientists, automation engineers, and AI/machine learning scientists guided by a set of common values.
ASSUMPTION OF GOOD INTENT
We assume others have good intentions.
CALCULATED RISK
We take calculated risks and push the boundaries of technology.
INTEGRITY
We operate with integrity and value quality in our products and services.
TEAM MEMBER VALUE
We value our team members and encourage investment in professional development.
VOICE
We value diverse perspectives and encourage open communication.
HARMONY
We encourage a harmonious and respectful work environment.
UNIFIED TEAM
We support and help our colleagues through teamwork and collaboration.
NOVEL APPROACH
We are open to new ideas and approaches in all areas of the business.
Our team's mission
Life-saving drugs, delivered better
We're accelerating drug development and manufacturing using the latest breakthroughs in AI, Robotics, and pharmaceutical sciences.
We aspire to "deliver better" because we want patients to receive life-saving drugs, faster, with fewer side effects, and to maintain a higher quality of life.
Our Founders
KARTHIK RAMAN, PH.D
CEO
Karthik completed a Ph.D in Bioengineering with a focus on drug delivery to the brain from the University of Utah. He has over 10 years of experience across drug delivery, automation, and machine learning.
CHRISTOPHER SHELNER, M.S, CSSBB
COO
Chris is a mechanical engineer by training and an expert in organizational strategy. He has worked across automation, synthetic biology, and electronics manufacturing in Northrop Grumman, Infineon and Zymergen over his career.
West Sacramento, CA (HQ)
Our headquarters is located in West Sacramento, CA. Within our US facilities we have our robotic lab as well as several local partnerships and cGMP facilities.
Pangyo, South Korea
We launched our South Korean subsidiary in 2023, with the support of the Korean government, to service generic drug developers, innovators, and cosmetic manufacturers in Korea.
Bangalore, India
In 2024, we launched our Indian subsidiary in Bangalore to support the strong generic industry and the rapid growth of innovative pharmaceutical drug developers
Partners & Investors
